Literature DB >> 16100367

Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets.

E A Plantinga1, H Everts, A M C Kastelein, A C Beynen.   

Abstract

A retrospective study was carried out on the efficacy of seven commercial diets designed to be fed to cats with chronic renal failure. The median survival time of 175 cats that received conventional diets was seven months, whereas the median survival time of 146 cats given one of the seven diets was 16 months. The cats on the most effective of the diets had a median survival time of 23 months and those on the least effective diet had a median survival time of 12 months. The composition of the seven diets was comparable, except that the most effective diet had a particularly high content of eicosapentaenoic acid.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16100367     DOI： 10.1136/vr.157.7.185

Source DB:  PubMed          Journal:  Vet Rec        ISSN： 0042-4900            Impact factor:   2.695


  16 in total

1.  Tolerability and efficacy of the intestinal phosphate binder Lantharenol® in cats.

Authors:  Bernard H Schmidt; Ute Dribusch; Peet C Delport; Jürgen M Gropp; F Josef van der Staay
Journal:  BMC Vet Res       Date:  2012-02-06       Impact factor: 2.741

2.  Case-control study of risk factors associated with feline and canine chronic kidney disease.

Authors:  Paul C Bartlett; James W Van Buren; Andrew D Bartlett; Chun Zhou
Journal:  Vet Med Int       Date:  2010-09-20

Review 3.  Therapeutic Effect of EPA/DHA Supplementation in Neoplastic and Non-neoplastic Companion Animal Diseases: A Systematic Review.

Authors:  Tomás Rodrigues Magalhães; Ana Luísa Lourenço; Hugo Gregório; Felisbina Luísa Queiroga
Journal:  In Vivo       Date:  2021-04-28       Impact factor: 2.406

4.  Efficacy, acceptability and tolerability of the new oral phosphate binder Lenziaren® in healthy cats fed a standard diet.

Authors:  Jonathan N King; Heidi L Erasmus; Peet C Delport; Ina Cj Bester; Wolfgang Seewald
Journal:  BMC Vet Res       Date:  2014-10-28       Impact factor: 2.741

5.  Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease.

Authors:  J A Hall; M Yerramilli; E Obare; M Yerramilli; D E Jewell
Journal:  J Vet Intern Med       Date:  2014-09-17       Impact factor: 3.333

6.  Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease.

Authors:  D Hendrik N van den Broek; Yu-Mei Chang; Jonathan Elliott; Rosanne E Jepson
Journal:  J Vet Intern Med       Date:  2018-04-27       Impact factor: 3.333

7.  Cats with IRIS stage 1 and 2 chronic kidney disease maintain body weight and lean muscle mass when fed food having increased caloric density, and enhanced concentrations of carnitine and essential amino acids.

Authors:  Jean A Hall; Dale A Fritsch; Dennis E Jewell; Patricia A Burris; Kathy L Gross
Journal:  Vet Rec       Date:  2018-12-04       Impact factor: 2.695

8.  Comparative palatability of five supplements designed for cats suffering from chronic renal disease.

Authors:  Natalia Bernachon; Sandrine Fournel; Hugues Gatto; Patricia Monginoux; David McGahie
Journal:  Ir Vet J       Date:  2014-05-19       Impact factor: 2.146

9.  Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Cats.

Authors:  Jean A Hall; Jennifer MacLeay; Maha Yerramilli; Edward Obare; Murthy Yerramilli; Heidi Schiefelbein; Inke Paetau-Robinson; Dennis E Jewell
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

10.  Acceptance and effects of a therapeutic renal food in pet cats with chronic kidney disease.

Authors:  Dale A Fritsch; Dennis E Jewell; P S Leventhal; J Brejda; N W Ahle; H M Schiefelbein; S D Forrester
Journal:  Vet Rec Open       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.